Management of Heart Failure Caused Primarily by Left Ventricular Systolic Dysfunction

References

• Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E: Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995; 92: 3593–3612.
   PubMed Web of Science ®Google Scholar
• O'Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13 Suppl: S107–S112.
   Google Scholar
• Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, Kobashigawa J, Walden J: Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990; 66: 1348–1354.
   PubMed Web of Science ®Google Scholar
• Franciosa JA, Wilen M, Ziesche S, Cohn JN: Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1983; 51: 831–836.
   PubMed Web of Science ®Google Scholar
• Likoff MJ, Chandler SL, Kay HR: Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987; 59: 634–638.
   PubMed Web of Science ®Google Scholar
• Chatterjee KJ: Systolic ventricular failure, chap 3. In Parmley WW, Chatterjee KJ, eds: Cardiology. Philadelphia: J. B. Lippincott Company, 1994: 1–43.
   Google Scholar
• Captopril-Digoxin Multicenter Research Group: Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA 1988; 259: 539–544.
   PubMed Web of Science ®Google Scholar
• DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320: 677–683.
   PubMed Web of Science ®Google Scholar
• Uretsky BF, Young JB, Shahidi E, Yellen LG, Harrison MC, Jolly MK: Randomized study assessing the effect of digoxin in patients with mild to moderate chronic heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955–962.
   PubMed Web of Science ®Google Scholar
• Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 1993; 329: 1–7.
   PubMed Web of Science ®Google Scholar
• Ward RE, Gheorghiade M, Young JB, Uretsky B: Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 1995; 26: 93–101.
   PubMed Web of Science ®Google Scholar
• Funke Küpper AJ, Fintelman H, Huige MC, Koolen JJ, Liem KL, Lustermans FA: Cross-over comparison of the fixed combination of hydrochlorothiazide and triamterene and the free combination of furosemide and triamterene in the maintenance treatment of congestive heart failure. Eur J Clin Pharmacol 1986; 30: 341–343.
   Web of Science ®Google Scholar
• Richardson A, Scriven AJ, Poole-Wilson PA, Bayliss J, Parameshwar J, Sutton GC: Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure. Lancet 1987; 2: 709–711.
   Web of Science ®Google Scholar
• Pitt B: “Escape” of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin-converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther 1995; 9: 145–149.
   PubMed Web of Science ®Google Scholar
• CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987,316: 1429–1435.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fletcher RD, Doherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992; 327: 669–677.
   PubMed Web of Science ®Google Scholar
• SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293–302.
   PubMed Web of Science ®Google Scholar
• Acute Infarction Ramipril Efficacy (AIRE) Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–828.
   Web of Science ®Google Scholar
• Ambrosioni E, Borghi C, Magnani B: The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995; 332: 80–85.
   PubMed Web of Science ®Google Scholar
• Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450–1456.
   PubMed Web of Science ®Google Scholar
• Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547–1552.
   PubMed Web of Science ®Google Scholar
• Hjalmarson A, Waagstein F: The role of β-blockers in the treatment of cardiomyopathy and ischaemic heart failure. Drugs 1994; 47 (4 Suppl): 31–40.
   Google Scholar
• Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441–1446.
   PubMed Web of Science ®Google Scholar
• CIBIS Investigators and Committees: A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994; 90: 1765–1773.
   PubMed Web of Science ®Google Scholar
• Australia-New Zealand Heart Failure Research Collaborative Group: Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995; 92: 212–218.
   PubMed Web of Science ®Google Scholar
• Krum H, Sakner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J, Medina N, Yushak M, Horn E, Katz SD, Levin HR, Neuberg GW, DeLong G, Packer M: Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 1995; 92: 1499–1506.
   PubMed Web of Science ®Google Scholar
• Littler WA, Sheridan DJ: Placebo controlled trial of felodipine in patients with mild to moderate heart failure. British Heart Journal 1995; 73: 428–433.
   PubMedGoogle Scholar
• Johnston O: Angiotensin receptor antagonists: focus on losartan. Lancet 1995; 346: 1403–1407.
   PubMed Web of Science ®Google Scholar
• Dickstein K, Chang P, Willenheimer R, Haunso S, Remes J, Hall C, Kjekshus J: Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol 1995; 26: 438–445.
   PubMed Web of Science ®Google Scholar
• Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck JE, Hendrix GH, Powers ER, Bain RP, White BG: Effects of vesnarinone on morbidity and mortality in patients with heart failure. N Engl J Med 1993; 329: 149–155.
   PubMed Web of Science ®Google Scholar